Direct Acting Antiviral-Post Authorization Safety Study
Public ClinicalTrials.gov record NCT03707080. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
DAA-PASS: A Post-Authorisation Safety Study of Early Recurrence of Hepatocellular Carcinoma in HCV-Infected Patients After Direct-Acting Antiviral Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is an independent optional sub-study parallel to TARGET-HCC (NCT02954094). The purpose of Direct-Acting Antiviral-Post Authorization Safety Study (DAA-PASS) is to investigate the impact of exposure to direct-acting antivirals (DAAs) on early recurrence of hepatocellular carcinoma (HCC) in hepatitis C virus (HCV)-infected patients following successful HCC treatment interventions.
Study identification
- NCT ID
- NCT03707080
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 42 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 9, 2018 (Actual)
- Primary completion
- Jun 30, 2021 (Actual)
- Completion
- Jun 30, 2021 (Actual)
- Last update posted
- Jul 6, 2021
2018 – 2021
United States locations
- U.S. sites
- 47
- U.S. states
- 25
- U.S. cities
- 40
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Banner University Medical Center | Phoenix | Arizona | 85006 | — |
| University of Arkansas for Medical Sciences | Little Rock | Arkansas | 72205 | — |
| Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | — |
| Stanford University | Palo Alto | California | 94304 | — |
| California Liver Research Institute | Pasadena | California | 91105 | — |
| University of California - Davis Clinical Trials | Sacramento | California | 95817 | — |
| University of California - San Francisco | San Francisco | California | 94158 | — |
| Georgetown University | Washington D.C. | District of Columbia | 20007 | — |
| Gastro Florida | Clearwater | Florida | 33762 | — |
| University of Florida Hepatology Research at CTRB | Gainesville | Florida | 32610 | — |
| University of Florida - Health Gastroenerology | Jacksonville | Florida | 32207 | — |
| Schiff Center for Liver Diseases | Miami | Florida | 33136 | — |
| Tampa General Medical Group | Tampa | Florida | 33606 | — |
| Piedmont Atlanta Hospital | Atlanta | Georgia | 30309 | — |
| Emory University Hospital | Atlanta | Georgia | 30322 | — |
| Northwestern University Division of Gastroenterology and Hepatology | Chicago | Illinois | 60611 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| University of Iowa Hospitals and Clinics | Iowa City | Iowa | 52242 | — |
| Tulane University School of Medicine | New Orleans | Louisiana | 70112 | — |
| Mercy Medical Center | Baltimore | Maryland | 21202 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
| University of Michigan | Ann Arbor | Michigan | 48109 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| Southern Therapy and Advanced Research LLC | Jackson | Mississippi | 39216 | — |
| Saint Louis University | St Louis | Missouri | 63110 | — |
| Rutgers-Robert Wood Johnson Medical School | New Brunswick | New Jersey | 08901 | — |
| Northwell Health - Center for Liver Disease | Manhasset | New York | 11030 | — |
| New York University Langone Health | New York | New York | 10016 | — |
| Weill Cornell Medical College | New York | New York | 10021 | — |
| Columbia University Medical Center | New York | New York | 10032 | — |
| Carolinas HealthCare System Center for Liver Disease | Charlotte | North Carolina | 28204 | — |
| Providence Health & Services Cancer Clinical Trials | Portland | Oregon | 97213 | — |
| Penn State Hershey Medical Center | Hershey | Pennsylvania | 17033 | — |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29403 | — |
| Vanderbilt University Medical Center - GI Research Office | Nashville | Tennessee | 37212 | — |
| Clinical Research Institute@ Methodist Dallas Medical Center | Dallas | Texas | 75203 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | — |
| Baylor Scott & White All Saints | Fort Worth | Texas | 76104 | — |
| Research Specialists of Texas | Houston | Texas | 77030 | — |
| Research Specialists of Texas | Houston | Texas | 77033 | — |
| University of Virginia Transplant Center | Charlottesville | Virginia | 22908 | — |
| Bon Secours Liver Institute of Virginia | Richmond | Virginia | 23226 | — |
| Virginia Commonwealth University | Richmond | Virginia | 23298 | — |
| Harborview Medical Center | Seattle | Washington | 98104 | — |
| Wenatchee Valley Hospital & Clinics | Wenatchee | Washington | 98801 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03707080, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 6, 2021 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03707080 live on ClinicalTrials.gov.